Animal models of optic nerve diseases

Eye

Volumn 18, Issue 11, 2004, Pages 1066-1074

  Levkovitch Verbin, H ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; FLUOROGOLD; INDIAN INK; MITOCHONDRIAL ENZYME; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PHOTOSENSITIZING AGENT; PROTEOLIPID PROTEIN; REACTIVE OXYGEN METABOLITE; RHODAMINE; ROTENONE; SODIUM CHLORIDE;

ALLERGIC ENCEPHALOMYELITIS; ARGON LASER; ARTICLE; CAUTERIZATION; CELL KILLING; CRUSH TRAUMA; DISEASE MODEL; GLAUCOMA; INTRAOCULAR PRESSURE; ISCHEMIC OPTIC NEUROPATHY; LASER COAGULATION; LEBER HEREDITARY OPTIC NEUROPATHY; MEDICAL RESEARCH; MONKEY; MOUSE; MULTIPLE SCLEROSIS; NERVE TRANSECTION; NONHUMAN; OPTIC NERVE DISEASE; OPTIC NERVE INJURY; RAT; RETINA GANGLION CELL;

EID: 9944260347     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701576     Document Type: Article

References (61)

1. Paigen K. A miracle enough: the power of mice. Nature Med 1995; 1: 215-220.
2. John SW, Anderson MG, Smith RS. Mouse genetics: a tool to help unlock the mechanisms of glaucoma. J Glaucoma 1999; 8 6): 400-412.
3. Cioffi GA, Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur J Ophthalmol 1999; 9(Suppl 1): S34-S36.
4. Wang RF, Schumer RA, Serle JB, Podos SM. A comparison of argon laser and diode laser photocoagulation of the trabecular meshwork to produce the glaucoma monkey model. J Glaucoma 1998; 7(1 : 45-49.
5. Gaasterland D, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol 1974; 13(6): 455-457.
6. Quigley HA, Hohman RM. Laser energy levels for trabecular meshwork damage in the primate eye. Invest Ophthalmol Vis Sci 1983; 24(9): 1305-1307.
7. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995; 36 5): 774-786.
8. Quigley HA. Experimental glaucoma damage mechanism. Arch Ophthalmol 1983; 101(8): 1301-1302.
9. Harwerth RS, Smith III EL, DeSantis L. Behavioral perimetry in monkeys. Invest Ophthalmol Vis Sci 1993; 34(1): 31-40.
10. Harwerth RS, Smith III EL, DeSantis L. Experimental glaucoma: perimetric field defects and intraocular pressure. J Glaucoma 1997; 6(6): 390-401.
11. Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. I. Production of elevated intraocular pressure by anterior chamber injection of autologous ghost red blood cells. Invest Ophthalmol Vis Sci 1980; 19(2): 126-136.
12. Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci 1980; 19(2): 137-152.
13. Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci 2002; 43(2): 402-410.
14. Johnson EC, Morrison JC, Farrell S, Deppmeier L, Moore CG, McGinty MR. The effect of chronically elevated intraocular pressure on the rat optic nerve head extracellular matrix. Exp Eye Res 1996; 62(6): 663-674.
15. Morrison J, Farrell S, Johnson E, Deppmeier L, Moore CC, Grossmann E. Structure and composition of the rodent lamina cribrosa. Exp Eye Res 1995; 60(2): 127-135.
16. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res 1997; 64(1): 85-96.
17. Moore CG, Epley D, Milne ST, Morrison JC. Long-term non-invasive measurement of intraocular pressure in the rat eye. Curr Eye Res 1995; 14(8): 711-717.
18. Jia L, Cepurna WO, Johnson EC, Morrison JC. Effect of general anesthetics on IOP in rats with experimental aqueous outflow obstruction. Invest Ophthalmol Vis Sci 2000; 41(11): 3415-3419.
19. Sawada A, Neufeld AH. Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp Eye Res 1999; 69(5): 525-531.
20. Shareef SR, Garcia-Valenzuela E, Salierno A, Walsh J, Sharma SC. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res 1995; 61(3): 379-382.
21. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 1995; 61(1): 33-44.
22. Ueda J, Sawaguchi S, Hanyu T, Yaoeda K, Fukuchi T, Abe H et al. Experimental glaucoma model in the rat induced by laser trabecular photocoagulation after an intracameral injection of India ink. Jpn J Ophthalmol 1998; 42(5): 337-344.
23. John SW, Hagaman JR, MacTaggart TE et al. Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci 1997; 38(1): 249-253.
24. McKinnon SJ, Reitsamer HA, Ransom NL, Caldwell M, Harrison JM, Kiel JW. Induction and tonopen measurement of ocular hypertension in C57BL/6 mice. ARVO abstract, poster 3319, 2003.
25. Cohan BE, Bohr DF. Measurement of intraocular pressure in awake mice. Invest Ophthalmol Vis Sci 2001; 42(11): 2560-2562.
26. Ahmed E, Ma J, Rigas I et al. Non-invasive tonometry in the mouse. ARVO abstract, poster 3336, 2003.
27. Danias J, Kontiola AI, Filippopoulos T, Mittag T. Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci 2003; 44(3): 1138-1141.
28. Mabuchi F, Aihara M, Lindsey R, Weinreb R. Mouse optic nerve axon loss is related to magnitude and duration of laser-induced ocular hypertension. ARVO abstract, poster 3333, 2003.
29. John SW, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 1998; 39(6): 951-962.
30. Chang B, Smith RS, Hawes NL et al. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet 1999; 21(4): 405-409.
31. Gould DB, John SW. Anterior segment dysgenesis and the developmental glaucomas are complex traits. Human Molecular Genesis 2002; 11(10): 1185-1193.
32. Gold R, Hartung HP, Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 2000; 6(2): 88-91.
33. Genain CP, Hauser SL. Experimental allergic encephalomyelitis in the New World monkey. Callithrix jacchus Immunol Rev 2001; 183: 159-172.
34. Barac-Latas V, Suchanek G, Breitschopf H, Stuehler A, Wege H, Lassmann H. Patterns of oligodendrocyte pathology in coronavirus-induced subacute demyelinating encephalomyelitis in the Lewis rat. Glia 1997; 19(1): 1-12.
35. Owens T, Sriram S. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol Clin 1995; 13(1): 51-73.
36. Raine CS, Traugott U, Nussenblatt RB, Stone SH. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis. Lab Invest 1980; 42(3): 327-335.
37. Rao NA. Chronic experimental allergic optic neuritis. Invest Ophthalmol Vis Sci 1981; 20(2): 159-172.
38. Adelmann M, Wood J, Benzel I et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 1995; 63(1): 17-27.
39. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994; 153(10): 4349-4356.
40. Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998; 8(4): 681-694.
41. Fisher J, Levkovitch-Verbin H, Schori H, Yoles E, Butovsky O, Kaye JF et al. Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J Neurosci 2001; 21 1): 136-142.
42. Berkelaar M, Clarke DB, Wang YC et al. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 1994; 14(7): 4368-4374.
43. Garcia-Valenzuela E, Gorczyca W, Darzynkiewicz Z, Sharma SC. Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol 1994; 25(4): 431-438.
44. Villegas-Perez MP, Vidal-Sanz M, Rasminsky M, Bray GM, Aguayo AJ. Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol 1993; 24 1): 23-36.
45. Solomon AS, Lavie V, Hauben U, Monsonego A, Yoles E, Schwartz M. Complete transection of rat optic nerve while sparing the meninges and the vasculature: an experimental model for optic nerve neuropathy and trauma. J Neurosci Methods 1996; 70(1): 21-25.
46. Agapova OA, Kaufman PL, Lucarelli MJ et al. Differential expression of matrix metalloproteinases in monkey eyes with experimental glaucoma or optic nerve transection. Brain Res 2003; 967(1-2): 132-143.
47. Duvdevani R, Rosner M, Belkin M et al. Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. Rest. Neurol. Neurosci. 1990; 2: 31-38.
48. Chierzi S, Strettoi E, Cenni MC, Maffei L. Optic nerve crush: axonal responses in wild-type and bcl-2 transgenic mice. J Neurosci 1999; 19(19): 8367-8376.
49. Yoles E, Wheeler LA, Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 1999; 40(1): 65-73.
50. Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, Wheeler LA, Schwartz M, Yoles E. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci 2000; 41(13): 4169-4174.
51. Gellrich NC, Schimming R, Zerfowski M, Eysel UT. Quantification of histological changes after calibrated crush of the intraorbital optic nerve in rats. Br J Ophthalmol 2002; 86 2): 233-237.
52. Bernstein SL, Yan G, Nguyen A, Flower R, Kelman SE, Johnson MA. A true model of anterior ischemic optic neuropathy (AION). ARVO abstract, poster 5019, 2001.
53. Goldenberg-Cohen N, Margolis F, Miller N, Bernstein S. Functional changes in a mouse model of anterior ischemic optic neuropathy. ARVO abstract, poster 3677, 2002.
54. Goldenberg-Cohen N, Miller NR, Guo Y, Margolis F, Bernstein SL. Anterior ischemice optic neuropathy alters RGC and oligodendrocyte function. ARVO abstract, poster 4556, 2003.
55. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nature Med 1997; 3(1): 73-76.
56. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 1994; 6(5): 712-724.
57. Yoles E, Schwartz M. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp Neurol 1998; 153(1): 1-7.
58. Levkovitch-Verbin H, Quigley HA, Kerrigan-Baumrind LA, D'Anna SA, Kerrigan D, Pease ME. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci 2001; 42(5): 975-982.
59. Levkovitch-Verbin H, Quigley HA, Martin KR, Zack DJ, Pease ME, Valenta DF. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest Ophthalmol Vis Sci 2003; 44(8): 3388-3393.
60. Zhang X, Jones D, Gonzalez-Lima F. Mouse model of optic neuropathy caused by mitochondrial complex I dysfunction. Neurosci Lett 2002; 326(2): 97-100.
61. Qi X, Lewin AS, Hauswirth WW, Guy J. Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Invest Ophthalmol Vis Sci 2003; 44(3): 1088-1096.